cfDNA (circulating DNA or cell-free DNA) are fragments of DNA that are released into the blood.
Elevated levels are seen in cancer and they can be detected using 'liquid biopsies' to aid diagnosis. Fetal cfDNA can be detected in maternal blood through non-invasive prenatal testing.
A blood test that screens for fetal disorders during pregnancy also accurately signposts cancers in unsuspecting mothers-to-be...
A new blood test to detect colon cancer has been approved by the United States Food and Drug Administration...
A Canadian DNA testing company sold prenatal paternity tests to customers knowing the results were inaccurate, an investigation revealed...
A new epigenomic blood test may distinguish between cancerous and benign ovarian tumours with greater accuracy than current tests...
A blood test taken in the first trimester of pregnancy to measure cell-free DNA methylation can help to predict the risk of preterm pre-eclampsia...
Results from an NHS-based clinical trial show the potential of a blood test to detect over 50 types of cancer...
A Texas court has awarded $100 million more damages to a company whose patents for non-invasive prenatal testing technology were infringed by a competitor...
Prenatal genetic test results need to be communicated better, according to the US Food and Drug Administration...
Health regulators in five countries are investigating non-invasive prenatal test NIFTY, over data protection concerns....
Non-invasive prenatal testing to detect chromosomal abnormalities in twin pregnancies is not as accurate as in singleton pregnancies...
Join our list to stay up-to-date on all the latest developments in the fields of human fertility and genomics.
Upcoming event
28 May 2025 | 6.30pm - 8.00pm | Free event
Location: Edinburgh, EH8 9TJ
